Edgewise Therapeutics (EWTX) Shares Issued (2020 - 2026)

Edgewise Therapeutics has reported Shares Issued over the past 7 years, most recently at $12.2 million for Q1 2026.

  • Quarterly results put Shares Issued at $12.2 million for Q1 2026, up 438.39% from a year ago — trailing twelve months through Mar 2026 was $17.7 million (up 107.51% YoY), and the annual figure for FY2025 was $7.8 million, up 778.72%.
  • Shares Issued reached $12.2 million in Q1 2026 per EWTX's latest filing, up from -$179.6 million in the prior quarter.
  • Across five years, Shares Issued topped out at $239.1 million in Q1 2024 and bottomed at -$235.6 million in Q2 2024.
  • Median Shares Issued over the past 5 years was $105000.0 (2022), compared with a mean of $1.3 million.
  • Peak annual rise in Shares Issued hit 1138695.24% in 2024, while the deepest fall reached 74435.65% in 2024.
  • Over 5 years, Shares Issued stood at -$129.3 million in 2022, then skyrocketed by 100.42% to $541000.0 in 2023, then fell by 14.05% to $465000.0 in 2024, then plummeted by 38714.84% to -$179.6 million in 2025, then soared by 106.78% to $12.2 million in 2026.
  • Business Quant data shows Shares Issued for EWTX at $12.2 million in Q1 2026, -$179.6 million in Q4 2025, and $186.8 million in Q3 2025.